Table 2.
Measure | B6N | B6J | |||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Univariate | ||||||||
p value (α =0.0036) | Alc-Chow | Alc-PF | Chow-PF | p value (α =0.0036) | Alc-Chow | Alc-PF | Chow-PF | ||
Width | minimal frontal | 0.0001* | 0.001* | 1.00 | 0.001* | 0.30 | |||
bitragal | 0.0001* | 0.22 | 0.001* | 0.0001* | 0.07 | ||||
bigonial | 0.0001* | 0.71 | 0.0001* | 0.001* | 0.92 | ||||
inner canthal | 0.0001* | 0.0001* | 0.88 | 0.11 | 0.24 | ||||
outer canthal | 0.0002* | 0.03* | 0.17 | 0.0001* | 0.09 | ||||
^ palpebral fissure | 0.0001* | 0.0001* | 0.09 | 0.009* | 0.02 | ||||
whisker pad | 0.0001* | 0.21 | 0.008* | 0.0001* | 0.0001* | 0.0001* | 0.10 | 0.0001* | |
columella | 0.0027* | 0.004* | 0.02* | 0.75 | |||||
Depth | ^ upper face | 0.0019* | 0.002* | 0.03° | 0.20 | 0.0001* | 0.0001* | 0.0001* | 0.80 |
^ mid face | 0.0001* | 0.0001* | 0.008* | 0.25 | 0.0001* | 0.001* | 0.0001* | 0.58 | |
^ lower face | 0.28 | 0.004 | |||||||
Height | nasal length | 0.0001* | 0.0001* | 0.0001* | 0.12 | 0.005* | |||
nasal bridge | 0.0001* | 0.0001* | 0.012* | 0.05 | 0.008* | ||||
philtrum | 0.20 | 0.12 | |||||||
lower facial height | 0.80 | 0.002* | 0.12 | 0.001* | 0.35 |
B6N: MANOVA (n=84); Hotelling’s Trace F(30,70)=3.7, p<0.0001; Univariate adjusted alpha = 0.0033; n’s=94–113 B6J: MANOVA (n=78); Hotelling’s Trace F(30,65)=4.9, p<0.0001; Univariate adjusted alpha = 0.0033; n’s=98–118
Measure taken on left side;
significant treatment effect, a=0.0033; *p<0.05, Tukey-Kramer;
p=0.05, Tukey-Kramer.
Gray shaded area represents measurements for both Alc-PF and Alc-Chow groups that show significant differences.